Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ombretta Turriziani

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2011
Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapyFrancesca Falasca, Paola Maida, Claudia Montagna, et al.
AIDS Research and Human Retroviruses|May 30, 2008
Study of the genotypic resistant pattern in HIV-infected women and children from rural west CameroonOmbretta Turriziani, Gianluca Russo, Miriam Lichtner, et al.
The New Microbiologica|November 8, 2016
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patientsRosa Sessa, Marisa Di Pietro, Simone Filardo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 29, 2020
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patientsGuido Antonelli, Ombretta Turriziani, Alessandra Pierangeli, et al.
Journal of Medical Virology|March 25, 2008
Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapyOmbretta Turriziani, Nicola Gianotti, Francesca Falasca, et al.
Frontiers in Immunology|June 6, 2018
Tumor-Targeting Anti-CD20 Antibodies Mediate <i>In Vitro</i> Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and <i>In Vivo</i> PrimingCristina Capuano, Simone Battella, Chiara Pighi, et al.
AIDS Research and Human Retroviruses|October 17, 2014
V3 net charge: additional tool in HIV-1 tropism predictionClaudia Montagna, Elisa De Crignis, Isabella Bon, et al.
The New Microbiologica|February 5, 2010
Thymidine kinase and deoxycytidine kinase in HIV-infected childrenFrancesca Falasca, Paola Maida, Arianna Boni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 6, 2022
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuationGuido Antonelli, Daniele Focosi, Ombretta Turriziani, et al.
The Lancet. Microbe|May 10, 2021
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swabGuido Antonelli, Emanuela Anastasi, Fabrizio Ciprani, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2011
Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapyFrancesca Falasca, Paola Maida, Claudia Montagna, et al.
AIDS Research and Human Retroviruses|May 30, 2008
Study of the genotypic resistant pattern in HIV-infected women and children from rural west CameroonOmbretta Turriziani, Gianluca Russo, Miriam Lichtner, et al.
The New Microbiologica|November 8, 2016
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patientsRosa Sessa, Marisa Di Pietro, Simone Filardo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 29, 2020
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patientsGuido Antonelli, Ombretta Turriziani, Alessandra Pierangeli, et al.
Journal of Medical Virology|March 25, 2008
Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapyOmbretta Turriziani, Nicola Gianotti, Francesca Falasca, et al.
Frontiers in Immunology|June 6, 2018
Tumor-Targeting Anti-CD20 Antibodies Mediate <i>In Vitro</i> Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and <i>In Vivo</i> PrimingCristina Capuano, Simone Battella, Chiara Pighi, et al.
AIDS Research and Human Retroviruses|October 17, 2014
V3 net charge: additional tool in HIV-1 tropism predictionClaudia Montagna, Elisa De Crignis, Isabella Bon, et al.
The New Microbiologica|February 5, 2010
Thymidine kinase and deoxycytidine kinase in HIV-infected childrenFrancesca Falasca, Paola Maida, Arianna Boni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 6, 2022
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuationGuido Antonelli, Daniele Focosi, Ombretta Turriziani, et al.
The Lancet. Microbe|May 10, 2021
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swabGuido Antonelli, Emanuela Anastasi, Fabrizio Ciprani, et al.
Pageof 12